Mercodia Equine Insulin ELISA is a species-optimized, high-quality enzyme immunoassay for the quantification of equine insulin in serum or plasma. Mercodia Animal Insulin Control (10-1221-01) is designed to be used as a three-level control for Porcine Insulin ELISA.
Control set containing rat and mouse insulin and rat C-peptide to be used in the rat and mouse insulin kits as well as in Rat C-peptide ELISA. Perform the Mercodia ELISA according to the "Directions for Use", handling Diabetes Antigen Control Rat&Mouse (Low, Medium, High) as samples. The controls contain rat insulin, mouse insulin, and rat C-peptide
ELISA kit for quantitative determination of rat and mouse proinsulin in serum, plasma, cell culture media or tissue homogenate.
An assay for the quantitative determination of porcine C-peptide in serum, plasma and cell culture medium. The assay may be used for post-transplant assessment of porcine islet xenograft function in human, macaque, rat or mouse. Enables distinguishing endogenously produced C-peptide for pharmacodynamic and/or pharmacokinetic studies during exogenous insulin administration.
Mercodia Glucagon ELISA – 10 µL is a highly specific and sensitive immunoassay for measuring glucagon in serum, EDTA plasma, and cell culture media samples from rat, mouse, and non-human primates. A revolutionizing ELISA for sensitive and specific determination of glucagon in rat, mouse, and non-human primate (NHP) samples. A research tool advancement that allows science to take the next step.
Mercodia GLP-1 (9-36) Amide Control – Low, Medium, High is a three-level control for Mercodia Total GLP-1 ELISA (10-1278-01). The Mercodia GLP-1 (9-36) Amide Control – Low, Medium, High contains synthetic GLP-1 (9-36) amide in stabilized serum. The content of each vial is lyophilized, containing 500 µL after reconstitution.
With over 30 years of experience developing and manufacturing ELISAs and ligand binding assays for commercial use, Mercodia has a profound understanding of product lifecycle management. To ensure that the assays we develop for drug development are reliable, accurate, and precise, we have product development procedures in place that cover all phases of the lifecycle from design, development, and validation to routine use.
Development and validation of Anti-Drug Antibody (ADA) assays for screening, confirmation and titer, and Neutralizing Antibody (NAb) assays.
Mercodia offers multiple solutions for the life science industry including custom production of assay kits, buffers, coated plates, and key components.
The Mercodia Lp(a) ELISA is a solid phase two-site enzyme immunoassay based on the sandwich technique, in which two monoclonal antibodies are directed against separate antigenic determinants on the apolipoprotein(a) molecule. Apolipoprotein(a) in the sample reacts with anti-apolipoprotein(a) antibodies bound to microtitration wells and peroxidase-conjugated anti-apolipoprotein(a) antibodies in the solution.
